How research shapes health policy on Capitol Hill

Jared Perkins, director of health policy strategy at Brown's Center for Advancing Health Policy through Research, offers insights into the challenges of influencing health policy under a shifting political landscape and how researchers help shape federal health care decisions.

At universities all over the country, academics conduct research about how to improve our health care system. But how does their work actually get put into practice? A growing number of universities are starting to send staff to Capitol Hill to bridge the gap between academics and policymakers. Jared Perkins is one of those people. 

Jared works for the Center for Advancing Health Policy through Research, sometimes called CAHPR, a part of Brown University's School of Public Health. Jared joined us to explain how research gets to policymakers, and offered an inside look into what health policy might look like under a second Trump administration. 

LISTEN TO THIS INTERVIEW

What is your primary role in representing Brown in Washington DC?

Researchers are constantly doing a ton of research—but it's in different academic journals. So my job is to bring together all of those findings, put them into one policy brief that really shows what they found and showcase some of the policy recommendations related to that. So really trying to bridge that gap from your wonky academic journal, bringing it into kind of terms that people can understand.

Policymakers want clear and concise information in a short amount of time. I know a lot of people will say things move slowly in Congress, but when they need something from academics or from researchers, it's usually at a quick turnaround. So it's a lot of trying to figure out how we can communicate our results in a way that's a good use of time to policymakers and really showcases the expertise and the resources that we have.

So how does this work actually get done?

So every congress I identify the five key areas where I think Congress is going to move on health policy. Then, what five key areas of research that might be of interest to the Hill, and I try to line those up. But then it's a lot of paying attention. So it's really identifying those key members who are going to be interested in our work instead of blindly going to offices who might not even be interested in health care.

Oftentimes when we're meeting with staff they're in the beginning stages of trying to figure out what kind of legislation to craft so you have to meet with them, inform them on the research and then they can craft a bill. Then you have to find co-sponsors, you have to find people across the aisle who might support your decision and get those bills through committee. Finally after you get those bills through committee, they’ve got to go through a floor vote. It can be a long, extensive process.

We're not an advocacy organization trying to push them to do one thing over the other. We're empowering them with the resources and the expertise that they need to make sure they're making the right decisions on behalf of people.

Jared Perkins Director of Health Policy Strategy, Center for Advancing Health Policy through Research
 
Man smiling

Are you seeing pushback around scientific research or expertise? How has that relationship evolved?

I believe there's still a want, especially at the staff level: 99% of them said that they want access to high-quality evidence-based research, but only 32% of them felt like they had that access. So I always feel like there is a want and a need from staff. 

Every time I go to the Hill and meet with staff, they seem excited to meet with us, just because we're not coming in there telling them what to do. We're not an advocacy organization trying to push them to do one thing over the other. We're going in there and saying, “We have all this incredible expertise and resources. How can we help you make the best policy decisions?” and empowering them with what they need to make sure they're making the right decisions on behalf of people.

But we also want it to be a two way street. We also want to be meeting with staff to know what questions they are trying to get answered. So that way we can incorporate it in our research and that way our research is more relevant to what policymakers are trying to figure out and decide. 

Republicans now have control of the presidency, House and Senate. Does that mean Republicans will make big changes to our health care policy? 

I think it's probably highly unlikely for major reforms to happen because the majorities are so slim in the House and the Senate. In the House, Speaker Johnson can't afford to really lose any votes, so it's hard to get consensus even within your own party to pass major reform. And I think the same thing in the Senate. So it's going to be a little bit tricky, at least from the congressional standpoint, to get major health care reform or anything like that done. But I think there's things that we could see on the margins.

Does that include budgets?

Yeah, I think the biggest one is going to be health care costs. I think in the election we saw the voters were concerned about the economy and the rising costs and health care affordability falls under that umbrella, right? And that's a lot of the research that's happening in the Center for Advancing Health Policy through Research: how do we make health care more affordable, more accessible and have higher quality?

So what other policy priorities are you seeing for 2025, besides cost?

Something that doesn't go away for policymakers each year is the opioid crisis. I think the Congress last year was supposed to get the SUPPORT Act reauthorization, which was a big comprehensive bill to address the opioid epidemic that was passed a while ago. Those programs are up for expiration. So now they need to reauthorize that. 

What would you say to people concerned about the incoming administration’s approach to health care services like vaccines? Are there going to be big changes to the way health care happens in this country?

Yeah, I try to keep a positive outlook because it helps me on a daily basis. I definitely think there's always cause for concern, but we just don't know what's going to happen and so until we know, it's really hard to say. I always look to the House and Senate Appropriations Committees, because these are the committees that fund the government every year. So when you think about major reforms to the NIH or CDC in terms of funding, those are the committees that have jurisdiction over that. And the leadership of those committees have always been very pro-science and pro-NIH on both sides of the aisle, and there's been a lot of bipartisanship around that. So that gives me some optimism and hope that there won't be huge significant cuts to NIH funding. 

What about someone like RFK Jr. getting confirmed to a cabinet position? What would you expect to see from him?

It's hard. The nomination process is going to be a long process. He's got to go through confirmation hearings. Anything can happen in those confirmation hearings. And then after they get through those hearings, he's got to pass with a simple majority in the Senate. And again they have a slim majority, so it may make it a little bit more difficult. I don't like guessing on whether he's gonna get passed or not because it's so hard to say right now until we get through the confirmation hearings. I think that's something republicans and Democrats have both always said is that we’ve got to give them a hearing before we make a decision.

I think when the president's budget drops in March, that'll also be a very strong signal of what some of their priorities are. We also might see a lot of career people get shifted around under the new administration. People who are in leadership could be moved to different positions. So seeing who they bring in underneath RFK. Jr. might be as important as RFK Jr.'s appointment itself. Those people are going to be shaping the different centers and the different administrations underneath HHS. 

So I don't know if I would say hit the panic button just yet, but I always try to remember that there are safeguards in place that keep them from just pushing through Congress. So I try to keep some optimism in that sense.